电邮这篇文章 The levels of resistin and other adipokines in patients with hypothyroidism
- 作者: Verbovaia NI1, Kapralova II.1, Verbovoĭ AF1
-
隶属关系:
- ГБОУ ВПО "Самарский государственный медицинский университет" Минздрава России
- 期: 卷 86, 编号 10 (2014)
- 页面: 33-35
- 栏目: Editorial
- URL: https://journal-vniispk.ru/0040-3660/article/view/31566
- ID: 31566
如何引用文章
全文:
详细
AIM. To investigate the relationship of resistin, adiponectin, leptin, and hormone metabolic parameters in patients with hypothyroidism. MATERIALS AND METHODS. Ninety-three women aged 58.0 (53.0-63.0) years with hypothyroidism were examined. A control group consisted of 10 women aged 48 (47-50) years. Anthropometric characteristics, glucose and lipid metabolic parameters, and leptin, resistin, adiponectin levels were studied. RESULTS. The patients with hypothyroidism were found to have statistically significantly enhanced insulin resistance (IR) and compensatory hyperinsulinemia in the presence of android fat distribution. The found atherogenic dyslipidemia manifested itself as an increase in the levels of total cholesterol, triglycerides, low-density lipoprotein cholesterol, and atherogenic index and as a reduction in high-density lipoprotein cholesterol. The concentration of leptin and resistin was increased and that of adiponectin was reduced in the patients with hypothyroidism. There was a correlation of leptin and adiponectin with fat metabolic parameters. CONCLUSION. The women with hypothyroidism had enhanced IR, as well as compensatory hyperinsulinemia in the presence of android fat distribution. Hypothyroidism is accompanied by the development of atherogenic dyslipidemia. The concentration of leptin and resistin was elevated and that of adiponectin was reduced in the examinees.
作者简介
N Verbovaia
ГБОУ ВПО "Самарский государственный медицинский университет" Минздрава России
Email: andreyy.verbovoyy@rambler.ru
I Kapralova
ГБОУ ВПО "Самарский государственный медицинский университет" Минздрава России
A Verbovoĭ
ГБОУ ВПО "Самарский государственный медицинский университет" Минздрава России
参考
- Аметов А.С. Избранные лекции по эндокринологии. М: Медицинские информационное агентство 2009; 496.
- Вербовой А.Ф. Гипотиреоз. Терапевт 2011; 12: 22-26.
- Фадеев В.В., Мельниченко Г.А. Гипотиреоз: руководство для врачей. М: РКИ Северопресс 2002; 216.
- Зефирова Г.С. Заболевания щитовидной железы. Арт-Бизнес-Центр 1999; 215.
- Соломонова Е., Вербовой А. Жировая ткань и адипокины. LAP. Lambert Academic Publishing 2012; 115.
- Петунина Н.А., Альтшулер Н.Э. Сравнительный анализ уровней адипонектина, лептина, резистина, показателей липидного обмена и инсулинорезистентности при субклиническом гипотиреозе в зависимости от наличия/отсутствия заместительной терапии левотироксином. Эндокринология. Новости. Мнения. Обучение 2013; 2: 27-31.
- Ройтберг Г.Е. Метаболический синдром. М: МЕДпресс-информ 2007; 224.
- Melon M., Wilsie L., Palyha O. et al. Discovery of a new role of human resistin in hepatocite low - density lipoprotein receptor suppression mediated in part by protein convertase subtilision/Kexin type 9. J Am Coll Cardiol 2012; 59 (19): 1697-1705.
- Guzik T.J., Manglat D., Korbut R. Adipocytokines - novel link beetween inflammation and vascular function. J Physiol Pharmacol 2006; 57 (4): 505-228.
- Farbid M. S., Ng T. W., Chan D. C. et al. Association of adiponectin and resistin with adipose tissue compartments, insulin resistans and dislipidaemia. Diabetes Obes Metab 2005; 7 (4): 406-413.
补充文件
